ID   CAL-27 2B3
AC   CVCL_C0RL
SY   Cal27 2B3; 2B3
DR   Wikidata; Q112929361
RX   PubMed=27108184;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (from parent cell line).
CC   Transfected with: HGNC; 6156; ITGB3.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C173807; Tongue adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1107 ! CAL-27
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
RX   PubMed=27108184; DOI=10.1016/j.bbamcr.2016.04.019;
RA   Stojanovic N., Brozovic A., Majhen D., Bosnar M.H., Fritz G.,
RA   Osmak M., Ambriovic-Ristov A.;
RT   "Integrin alphavbeta3 expression in tongue squamous carcinoma cells
RT   Cal27 confers anticancer drug resistance through loss of
RT   pSrc(Y418).";
RL   Biochim. Biophys. Acta 1863:1969-1978(2016).
//